In recent trading, shares of Core Laboratories N.V. (Symbol: CLB) have crossed above the average analyst 12-month target price of $22.50, changing hands for $23.57/share. When a stock reaches the ...

(1) Three months ended September 30, 2024 includes reversals of stock compensation expense previously recognized due to a change in probability of performance condition for certain executive's share ...

Gwendolyn Schreffler, Senior Vice President, projected Core's fourth quarter 2025 revenue to range from $132 million to $136 million with operating income of $14 million to $16.1 million and operating ...

CEO Lawrence V. Bruno highlighted that "Core continued to execute its strategic plan of technology investments targeted to both solve client problems and capitalize on Core's technical and geographic ...

due to a change in probability of performance conditions for certain executives' share awards. The year ended December 31, 2024 includes reversals of stock compensation expense previously recognized ...

Core Laboratories’ core analysis services in particular are a key element of oil and gas development, directly informing further reservoir analysis (seismic, wireline logging, and so on) that’s ...

probability of performance condition for certain executive's share awards. (2) Three months ended June 30, 2025 and September 30, 2025 includes the write-down of inventory. (3) Three months ended June ...